REGULATORYMarijuana Moment
Appeal challenges Medicare Advantage hemp and CBD coverage pilot
Marijuana prohibition groups and a pharmaceutical company filed an appellate brief seeking to block a CMS pilot that can cover up to $500 a year in qualifying hemp-derived products for eligible Medicare Advantage patients. The case could shape national reimbursement and market access for cannabinoid products, so Oklahoma operators should track the standing dispute and the government's response due November 4.
Published Oct 6, 2026
Read the full article at Marijuana Moment#national#hemp#litigation#market-access
Read the original source
Leafy summaries provide industry context. Confirm details with Marijuana Moment.